These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Advances in LDL-apheresis for the treatment of severe hypercholesterolemia.
    Author: Gordon BR, Saal SD.
    Journal: Curr Opin Lipidol; 1994 Feb; 5(1):69-73. PubMed ID: 15559033.
    Abstract:
    LDL-apheresis is an extracorporeal plasma-perfusion method that selectively removes apolipoprotein B-containing lipoproteins from the blood. It is indicated for patients with homozygous and drug-resistant heterozygous familial hypercholesterolemia. Clinical and angiographic regression of coronary artery disease has been demonstrated in patients treated with cholesterol-lowering programs that include LDL-apheresis.
    [Abstract] [Full Text] [Related] [New Search]